<DOC>
	<DOCNO>NCT00988533</DOCNO>
	<brief_summary>The purpose study determine bioavailability 0.5 % ivermectin cream pediatric population age 6 month 3 year .</brief_summary>
	<brief_title>A Pharmacokinetics ( PK ) Study Lice Infested Children 6 Months 3 Years Age</brief_title>
	<detailed_description />
	<mesh_term>Ivermectin</mesh_term>
	<criteria>Subject must 6 month 3 year age , inclusive , informed consent sign . Subject must infest head louse demonstrate presence least 1 live louse prior treatment . Subject general good health . Subject 's parent/guardian ( caregiver ) must willing able bring subject study visit schedule . Subject 's caregiver must provide write informed consent ( assent require due young age subject ) . Subject 's caregiver must agree comply follow study restriction : use form louse treatment ( eg , commercial , community/anecdotal , mechanical/manual ) subject duration study , unless direct study personnel . shampoo , wash , rinse subject 's hair scalp Day 2 treatment evaluation complete . cut chemically treat subject 's hair period screen followup Day 15. use studyprovided shampoo subject duration study . follow study instruction . Subjects receive OTC prescription treatment head louse last 2 week . Subjects subject ' caregiver unable comply study obligation study visit . Subjects whose caregiver understand requirement participation and/or may likely exhibit poor compliance , opinion Investigator . Subjects eczema , atopic dermatitis , chronic condition scalp skin . Subjects visible skin/scalp condition ( ) attributable head louse infestation , erythema score &gt; 2 , blister , condition , opinion investigative personnel Sponsor , would interfere PK , safety and/or efficacy evaluation . Subjects history allergy ivermectin ingredient commonly include hair product shampoo , hair conditioner , style aid . Subjects diagnose , opinion Investigator , would interfere PK , safety , and/or efficacy assessment would preclude study participation . Subjects treat systemic antibiotic within 2 week screen . Subject currently take warfarin sodium ( CoumadinÂ® ) take within 2 week screen . Subjects enrol clinical study within past 30 day ; subject may participate another study participate study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Head Lice</keyword>
	<keyword>Pediculus</keyword>
</DOC>